Breast Cancer Molecular Analysis Prior to Investigational Therapy
Observational Model: Case-Only, Time Perspective: Prospective
molecular analysis of metastatic breast cancer using DNA sequencing
The primary goal is to survey the known DNA abnormalities with potential therapeutic relevance in cancer and steer patients to therapies that target the detected abnormalities.
Lajos Pusztai, M.D., D.Phil
United States: Data and Safety Monitoring Board
|Smilow Hospital Breast Center||New Haven, Connecticut 06520-8032|